ADME of 14C-Telotristat Etiprate in Healthy Male Subjects (QBR114110)

• Research type

  Research Study

• Full title

  A Phase 1, Open-Label, Non-randomised, Single-dose Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate (LX1606), Following Oral Administration in Healthy Male Subjects

• IRAS ID

  128181

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Lexicon Pharmaceuticals Inc

• Eudract number

  2013-000681-11

• REC name

  HSC REC B

• REC reference

  13/NI/0065

• Date of REC Opinion

  24 Jun 2013

• REC opinion

  Further Information Favourable Opinion